Search
Adipiplon
go.drugbank.com/drugs/DB06579InvestigationalAdipiplon is an nonbenzodiazepine anxiolytic developed by Neurogen Corporation. It is known by the standardized identifier NG2-73.
Thymidine monophosphate
go.drugbank.com/drugs/DB01643InvestigationalA thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.
Mesenchymal stem cell-derived exosomes
go.drugbank.com/drugs/DB24445InvestigationalMesenchymal Stem Cell-Derived Exosomes is under investigation in clinical trial NCT07183384 (MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction).
Hydroxyethylpromethazine
go.drugbank.com/drugs/DB13840ExperimentalCategories: Antihistamines for Systemic UseCPZEN-45
go.drugbank.com/drugs/DB18077ExperimentalSynonyms: Uridine, 5'-o-(5-amino-5-deoxy-.beta.-d-ribofuranosyl)-5'-c-((2s)-5-(((4-butylphenyl)amino)carbonyl)-2,3,4,7-tetrahydro-1,4-dimethyl-3-oxo-1h-1,4-diazepin-2-yl)-, (5's)-Categories: Drugs for Treatment of TuberculosisLIS-1
go.drugbank.com/drugs/DB18388ExperimentalLIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.
KAI-1455
go.drugbank.com/drugs/DB06064ExperimentalIn preclinical studies, KAI-1455 showed a dramatic reduction in infarct size when delivered prior to the ischemic insult. … KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting
SR 121463
go.drugbank.com/drugs/DB05455InvestigationalIt is a candidate for control of hyponatremia and in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH).
Y-27632
go.drugbank.com/drugs/DB08756InvestigationalIt inhibits calcium sensitization to affect smooth muscle relaxation.